Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Nutex Health (NUTX) over the last 16 years, with Q3 2025 value amounting to $38.2 million.

  • Nutex Health's Change in Receivables rose 171520.91% to $38.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $324.7 million, marking a year-over-year increase of 253705.9%. This contributed to the annual value of $174.0 million for FY2024, which is 471357.11% up from last year.
  • Latest data reveals that Nutex Health reported Change in Receivables of $38.2 million as of Q3 2025, which was up 171520.91% from $54.1 million recorded in Q2 2025.
  • In the past 5 years, Nutex Health's Change in Receivables registered a high of $169.7 million during Q4 2024, and its lowest value of -$33.2 million during Q3 2022.
  • Its 5-year average for Change in Receivables is $14.8 million, with a median of $59390.0 in 2021.
  • The largest annual percentage gain for Nutex Health's Change in Receivables in the last 5 years was 9859008.6% (2021), contrasted with its biggest fall of 2566933.7% (2021).
  • Over the past 5 years, Nutex Health's Change in Receivables (Quarter) stood at -$30.2 million in 2021, then soared by 87.75% to -$3.7 million in 2022, then skyrocketed by 317.74% to $8.1 million in 2023, then soared by 2005.88% to $169.7 million in 2024, then crashed by 77.49% to $38.2 million in 2025.
  • Its Change in Receivables stands at $38.2 million for Q3 2025, versus $54.1 million for Q2 2025 and $62.6 million for Q1 2025.